Dr. Kelly is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1441 Eastlake Avenue
8302e
Los Angeles, CA 90033Phone+1 323-865-3105Fax+1 210-450-1150- Is this information wrong?
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 2008 - 2009
University College Cork Faculty of MedicineClass of 2001
Certifications & Licensure
TX State Medical License 2012 - 2026
CA State Medical License 2016 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma Start of enrollment: 2011 Oct 01
- Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma Start of enrollment: 2012 Apr 16
- Testing a New Chemotherapy Drug, KRT-232 (AMG-232) in Combination With Decitabine and Venetoclax in Patients With Acute Myeloid Leukemia Start of enrollment: 2018 Feb 08
Publications & Presentations
PubMed
- 1 citationsComprehensive Single-Cell Immune Profiling Defines the Patient Multiple Myeloma Microenvironment Following Oncolytic Virus Therapy in a Phase Ib Trial.Nawrocki, S., Olea, J., Villa Celi, C., Dadrastoussi, H., Wu, K., Tsao-Wei, D., Colombo, A., Coffey, M., Fernandez Hernandez, E., Chen, X., Nuovo, G., Carew, J., Mohrb...> ;Clinical Cancer Research. 2023 Dec 15
- 26 citationsVenetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial.Naval G Daver, Monique Dail, Jacqueline S Garcia, Brian A Jonas, Karen W L Yee, Kevin R Kelly, Norbert Vey, Sarit Assouline, Gail J Roboz, Stefania Paolini, Daniel A P...> ;Blood. 2023 Mar 16
- Characterization of BCMA Expression in Circulating Rare Single Cells of Patients with Plasma Cell Neoplasms.Libere J Ndacayisaba, Kate E Rappard, Stephanie N Shishido, Sonia M Setayesh, Guilin Tang, Pei Lin, Nicholas Matsumoto, Ching-Ju Hsu, Rafael Nevarez, Carmen Ruiz Velas...> ;International Journal of Molecular Sciences. 2022 Nov 3
- Join now to see all
Abstracts/Posters
- CUL1: Novel Therapeutic Target in Myeloid Neoplasms Harboring -7/Del(7q)Kevin R Kelly, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Incidence of Serious Adverse Events, Pneumonitis, Infection and Sepsis in Patients with Relapsed and Refractory Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphom...Kevin R Kelly, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Pharmacologic Normalization of Altered Transcriptome of SF3B1 Mutant Myeloid NeoplasiaKevin R Kelly, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
Wm. Kevin Kelly Appointed Chair of Medical Oncology at Thomas JeffersonJanuary 13th, 2023- Enzalutamide Induces Response in Certain Men with Prostate Cancer on Active SurveillanceAugust 5th, 2022
Hospital Affiliations
Keck Hospital of USCLos Angeles, California
USC Norris Comprehensive Cancer CenterLos Angeles, California
Los Angeles General Medical CenterLos Angeles, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
